Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Lyra Therapeutics (LYRA) has shared an announcement.
Lyra Therapeutics, Inc. has doubled the annual salary of its Executive Chair, Harlan Waksal, M.D., from $200,000 to $400,000, effective as of the start of 2024, following approval from its Board of Directors on February 26, 2024.
See more data about LYRA stock on TipRanks’ Stock Analysis page.
